Search

Your search keyword '"Adang, Laura A."' showing total 299 results

Search Constraints

Start Over You searched for: Author "Adang, Laura A." Remove constraint Author: "Adang, Laura A."
299 results on '"Adang, Laura A."'

Search Results

1. Correlation between age of onset and genotype with systemic symptomatology in Aicardi Goutières Syndrome

2. TREX1 is required for microglial cholesterol homeostasis and oligodendrocyte terminal differentiation in human neural assembloids

5. Systemic complications of Aicardi Goutières syndrome using real-world data

6. Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy

7. Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States

8. Longitudinal natural history studies based on real-world data in rare diseases: Opportunity and a novel approach

10. Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management

11. Nonverbal Cognitive Skills in Children With Aicardi Goutières Syndrome

12. Pulmonological issues

14. Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)

16. Systemic Complications and Natural History of Aicardi Goutières Syndrome (P6-8.001)

18. Characterization of Fine Motor and Visual Motor Skills in Aicardi-Goutières Syndrome

19. Effective Gene Therapy for Metachromatic Leukodystrophy Achieved with Minimal Lentiviral Genomic Integrations

20. Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of Multiple Sulfatase Deficiency

21. Inventory of current practices regarding hematopoietic stem cell transplantation in metachromatic leukodystrophy in Europe and neighboring countries

22. Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases

23. Framework for Multistakeholder Patient Registries in the Field of Rare Diseases:Focus on Neurogenetic Diseases

24. Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management

26. Nucleotide metabolism, leukodystrophies, and CNS pathology

27. Development of a rigorous approach for retrospective natural history studies in leukodystrophies

28. Validation of GMFC-MLD scale as a measure of gross motor function in metachromatic leukodystrophy

30. A phase 2 study assessing TAK-611150 mg intrathecal weekly in patients with late-infantile metachromatic leukodystrophy (SHP611–201; EMBOLDEN) compared to matched historical control data from children with late-infantile MLD (GLIA-MLD)

33. Systemic Complications of Aicardi Goutières Syndrome Using Real World Data

35. Biochemical signatures of disease severity in multiple sulfatase deficiency.

36. Biochemical signatures of disease severity in multiple sulfatase deficiency

37. Exploration of Gross Motor Function in Aicardi-Goutières Syndrome

38. Gross Motor Function in Pediatric Onset TUBB4A-Related Leukodystrophy: GMFM-88 Performance and Validation of GMFC-MLD in TUBB4A

42. Early developmental delay in Leigh syndrome spectrum disorders is associated with poor clinical prognosis

47. Developmental delay can precede neurologic regression in metachromatic leukodystrophy

49. SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome

Catalog

Books, media, physical & digital resources